Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
21st Century Brain Trust
Atlanta, Georgia, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
Approved for Phase I clinical trials in Australia for continuous intrathecal delivery of riluzole (IT-Riluzole) targeting ALS and other CNS diseases; equivalence to US standards allows direct progression to Phase II. Treated two patients off-label with no side effects, providing stable neuroprotection.
- Therapeutic areas
- Neurology
- Modalities
- Small molecule
- Industry
- Biotech
02
Partnerships
Flinders UniversitySunshine Coast Hospital
Beyond the preview
Go deeper on 21st Century Brain Trust.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on 21st Century Brain Trust.